Rajender R. Aparasu - Publications, H-index & Citations

Rajender R. Aparasu

college of pharmacy

38H指数

409论文数

4.9K被引数

收录论文 208

发表时间

Longitudinal Adherence Trajectories of First-Line Nucleotide Analogues among US Older Adults with Chronic Hepatitis B 美国慢性乙型肝炎老年患者中一线核苷类似物的纵向依从性轨迹

DRUGS & AGING

IF3.8

2026-09-06

PREAI

Javeria Khalid; Prasun Kumar Jalal; Jieni Li; Hua Chen; Xi Lu; Rajender R. Aparasu

DISCONTINUATION OF DISEASE-MODIFYING THERAPIES IN OLDER ADULTS WITH MULTIPLE SCLEROSIS 多发性硬化老年患者疾病修正疗法的终止

Multiple Sclerosis and Related Disorders

IF2.9

2026-07-06

PREAI

Jieni Li; George J. Hutton; Rajender R. Aparasu

Racial Disparities in Shared Decision Making Among Prostate Cancer Patients: A National Study 前列腺癌患者中共享决策中的种族差异：一项全国性研究

Journal of Racial and Ethnic Health Disparities

IF2.4

2026-05-04

PREAI

Jerusha Daggolu; Javeria Khalid; Rajender R. Aparasu

Safety and effectiveness of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease – A SEER-Medicare study 老年转移性非小细胞肺癌合并预存自身免疫性疾病患者中使用免疫检查点抑制剂的疗效与安全性——一项SEER-Medicare研究

Journal of Geriatric Oncology

IF2.7

2026-04-15

PREAI

Shrey Gohil; Hua Chen; Whitney E. Lewis; Meghana Trivedi; Rajender R. Aparasu; Michael L. Johnson

Treatment Adherence to Oral Direct-Acting Antiviral Agents in Hepatitis C Infection 乙型肝炎感染中口服直接抗病毒药物的治疗依从性

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

IF0

2026-04-07

PREAI

Javeria Khalid; Jieni Li; Rajender R. Aparasu

Predictors of severe immune-related adverse events during first-line immune checkpoint inhibitor therapy for advanced non-small cell lung cancer 晚期非小细胞肺癌患者接受一线免疫检查点抑制剂治疗期间发生严重免疫相关不良事件的预测因素

Scientific Reports

IF3.9

2026-04-04

OAAI

Olajumoke A. Olateju; Rajender R. Aparasu; Meera Patel; Tyler J. Varisco; Chan Shen; Meghana Trivedi; Ekere J. Essien; J. Douglas Thornton

Understanding initial medication adherence amongst major depressive disorder patients: A scoping review 了解重度抑郁症患者初始药物治疗依从性：一项范围综述

Journal of the American Pharmacists Association

IF2.5

2026-03-03

PREAI

Sourab Ganna; Javeria Khalid; Rajender Aparasu

Pain severity and opioid use in patients with spine-related diagnoses 脊柱相关诊断患者的疼痛严重程度和吗啡使用情况

Frontiers in Pain Research

IF2.7

2026-01-12

OAAI

Okeke, Chijioke M.; Khalid, Javeria; Thornton, J. Douglas; Aparasu, Rajender R.

Bayesian LASSO with Categorical Predictors: Coding Strategies, Uncertainty Quantification, and Healthcare Applications 贝叶斯LASSO与分类预测变量：编码策略、不确定性量化及医疗保健应用

FORECASTING

IF3.2

2025-11-21

PREAI

Lu, Xi; Li, Jieni; Aparasu, Rajender R.; Yusuf, Nebil; Wu, Cen

Comparative effectiveness and safety of glatopa and copaxone in patients with multiple sclerosis 奥贝妥珠单抗和奥法妥昔单抗在多发性硬化患者中的比较有效性与安全性

Multiple Sclerosis and Related Disorders

IF2.9

2025-09-13

PREAI

Ning Lyu; Jieni Li; George J. Hutton; Xinli Liu; Rajender R. Aparasu

Technological Tools to Improve Adherence Among the Geriatric Population with Major Depressive Disorder: A Narrative Review 提高重度抑郁症老年人群依从性的技术工具：一项叙事性综述

research in social administrative pharmacy

IF0

2025-09-01

PREAI

J.A. Patel; B.B. Phan-Tran; S. Ganna; R.R. Aparasu

Factors Associated with Initial Medication Adherence Amongst Those Diagnosed with Depressive 与抑郁症患者初始药物依从性相关的因素

research in social administrative pharmacy

IF0

2025-09-01

PREAI

S. Ganna; J. Khalid; R.R. Aparasu

Racial Variation In Shared Decision Making Among Prostate Cancer Patients: A National Survey Study 前列腺癌患者中种族差异对共享决策的影响：一项全国性调查研究的分析

research in social administrative pharmacy

IF0

2025-09-01

PREAI

J. Daggolu; J. Khalid; R.R. Aparasu

Factors associated with initial medication adherence with first-line therapy for depression 与抑郁症一线治疗初始药物依从性相关的因素

Journal of Affective Disorders

IF4.9

2025-08-05

PREAI

Sourab Ganna; Jieni Li; Rajender R. Aparasu

Association Between Gabapentinoid Use and Changes in Claims-Based Frailty Among Long-Term Opioid Users 加巴喷丁类药物使用与长期阿片类药物使用者基于理赔数据的衰弱状态变化之间的关系

Drugs & Aging

IF3.8

2025-06-18

PREAI

Jordan Westra; Mukaila Raji; Jacques Baillargeon; Rajender R. Aparasu; Yong-Fang Kuo

Response to comment on Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data 对关于老年阿尔茨海默病患者谵妄事件及相应治疗调整的评论的回应：一项基于Medicare数据的间断时间序列分析

PHARMACOTHERAPY

IF3.4

2025-01-23

PREAI

Aparasu, RR; Talwar, A

Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States

PREVENTIVE MEDICINE

IF3.2

2025-01-01

PREAI

Li, Jieni; Hutton, George J.; Varisco, Tyler J.; Lin, Ying; Essien, Ekere J.; Aparasu, Rajender R.

Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease

ARCHIVES OF GERONTOLOGY AND GERIATRICS

IF3.8

2025-01-01

PREAI

Chikermane, Soumya G.; Li, Jieni; Aparasu, Rajender R.

Infection Risk Associated with High-Efficacy Disease-Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-11-15

OAAI

Li, Jieni; Hutton, George J.; Varisco, Tyler J.; Lin, Ying; Essien, Ekere J.; Aparasu, Rajender R.

Factors associated with the use of immune checkpoint inhibitors in adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study

JOURNAL OF GERIATRIC ONCOLOGY

IF2.7

2024-11-01

PREAI

Gohil, Shrey; Chen, Hua; Lewis, Whitney E.; Trivedi, Meghana; Aparasu, Rajender R.; Johnson, Michael L.

研究方向